Published on:
March 28, 2026
GLP-1 weight loss drugs have rapidly become one of the most talked-about developments in modern medicine. Names like Ozempic, Wegovy, and Mounjaro now feature in daily headlines, celebrity interviews, and social media feeds — but behind the hype lies a complex medical decision that deserves careful, personalised guidance. If you're considering GLP-1 medications to support your weight loss journey, here's what your private GP genuinely wants you to understand before you begin.
GLP-1 receptor agonists are a class of medications originally developed to manage type 2 diabetes. GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone your body produces in response to eating. This hormone plays a crucial role in regulating blood sugar, slowing the rate at which your stomach empties, and signalling to your brain that you feel full.
The medications work by mimicking the effects of this natural hormone, but at much higher and more sustained levels than your body typically produces. The result is a significant reduction in appetite, fewer food cravings, and a slower digestive process that helps you feel satisfied with smaller portions. Some newer formulations, such as tirzepatide (sold as Mounjaro), target additional hormone receptors — specifically GIP (glucose-dependent insulinotropic polypeptide) — to amplify these effects further.
It's worth noting that these drugs don't simply "melt fat away" on their own. They create the physiological conditions that make it considerably easier to sustain a calorie deficit. Clinical trials have shown average weight losses of 15–20% of body weight over 68 weeks when combined with lifestyle modifications, which is a genuinely significant outcome for people living with obesity.
Not everyone who wants to lose a few pounds is a suitable candidate for GLP-1 therapy. In the UK, prescribing guidelines generally require patients to meet specific clinical criteria before these medications can be recommended. Understanding whether you qualify is one of the first conversations you'll have with your GP.
Typically, GLP-1 medications for weight management are considered appropriate for adults with a BMI of 30 or above (classified as obese), or a BMI of 27 or above with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnoea. You can check where you stand using our BMI calculator as a starting point, though your GP will take a far more comprehensive view of your health.
Your doctor will also review your full medical history, including previous weight loss attempts, current medications, family health history, and any conditions that might make GLP-1 drugs unsuitable. For example, these medications are generally not recommended for people with a personal or family history of medullary thyroid carcinoma, those with a history of pancreatitis, or women who are pregnant or planning to become pregnant in the near future.
It's also important to be honest about your expectations. GLP-1 drugs work best as part of a broader treatment plan that includes dietary changes, increased physical activity, and ongoing behavioural support. If you're looking for a quick fix without committing to lifestyle changes, your GP may suggest alternative approaches first. Our weight loss treatment service is designed to provide exactly this kind of holistic, supervised support.
Every medication comes with potential side effects, and GLP-1 drugs are no exception. The good news is that most side effects are gastrointestinal in nature and tend to improve as your body adjusts to the medication, typically within four to eight weeks. However, being prepared for them can make a real difference to your experience and your willingness to stick with treatment.
The most commonly reported side effects include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. Nausea is particularly prevalent during the dose-escalation phase — the period when your dose is being gradually increased to the target level. Starting at a lower dose and titrating upwards slowly is the standard approach to minimise these symptoms, and your GP will guide this process carefully.
Practical strategies can help enormously. Eating smaller, more frequent meals; avoiding high-fat or greasy foods; staying well hydrated; and eating slowly can all reduce the severity of nausea. Some patients find that keeping a symptom diary helps them identify specific triggers, which they can then discuss with their doctor at follow-up appointments.
While rare, more serious complications have been reported. These include pancreatitis (inflammation of the pancreas), gallbladder problems, and — in very rare cases — intestinal obstruction. Signs to watch for include severe, persistent abdominal pain, particularly if it radiates to your back, as well as jaundice or significant changes in bowel habits. These require immediate medical attention.
There's also growing clinical discussion around the risk of muscle mass loss alongside fat loss, particularly in patients who don't engage in resistance exercise. This is why your GP will likely emphasise the importance of incorporating strength training into your routine to preserve lean muscle mass during treatment.
One of the most critical messages your private GP wants you to hear is this: GLP-1 medications require ongoing medical supervision. Obesity is a chronic condition, and managing it effectively with these drugs is not a matter of simply collecting a prescription and going about your life. As obesity specialists frequently emphasise, this is a long-term medical relationship, not a one-off transaction.
Before starting treatment, your GP will likely arrange baseline blood tests to check your kidney function, liver function, blood glucose levels, thyroid function, and lipid profile. These tests serve a dual purpose: they help confirm your suitability for the medication and they establish a baseline against which your progress and any potential complications can be measured.
Regular follow-up appointments are essential throughout treatment. During these consultations, your GP will monitor your weight loss trajectory, assess for side effects, adjust your dose as needed, and review your overall health. They'll also check for nutritional deficiencies, which can occur when food intake is significantly reduced, and ensure that any other medications you take are still appropriately dosed — since weight loss can alter how your body processes other drugs.
This level of oversight is precisely why seeking GLP-1 treatment through a qualified medical professional is so important. Obtaining these medications through unregulated online sources or without proper medical assessment puts your health at unnecessary risk.
This is perhaps the question that doesn't get enough attention in the public conversation about GLP-1 medications, yet it's one of the most important things your GP wants you to consider before you start. Research consistently shows that the majority of people who discontinue GLP-1 drugs regain a significant proportion of the weight they lost, often around two-thirds within the first year after stopping.
This isn't a failure of willpower — it's a reflection of the underlying biology of obesity. When the medication is withdrawn, the hormonal signals that were suppressing appetite and slowing gastric emptying return to their previous levels. For many patients, the hunger and cravings they experienced before treatment come back, making it extremely difficult to maintain the calorie deficit needed to preserve their weight loss.
This reality has several implications. First, you should enter treatment understanding that it may need to be long-term, potentially indefinite, to maintain results. Second, the lifestyle changes you make during treatment — healthier eating patterns, regular exercise, improved sleep, and stress management — are not optional extras. They are the foundation upon which any lasting success is built. And third, if you do decide to stop the medication, your GP should help you develop a structured plan for tapering off gradually while intensifying other support strategies.
Having an honest conversation with your GP about the long-term nature of treatment is vital. Together, you can set realistic expectations and build a sustainable plan that accounts for all the variables.
Cost is a significant factor for many patients considering GLP-1 weight loss drugs. In the UK, NHS access to these medications for weight management is currently limited, with specific criteria and often long waiting lists. Private prescriptions offer a faster route to treatment but come with a notable financial commitment.
The monthly cost of GLP-1 medications through private clinics typically ranges from £150 to £300 or more, depending on the specific drug and the dose required. When you factor in the recommended duration of treatment — often a year or longer to achieve and begin to stabilise meaningful weight loss — the total expense can be substantial. It's essential to factor in the cost of regular GP consultations and blood tests as well.
Your GP can help you weigh the financial investment against the potential health benefits. For patients with obesity-related conditions such as type 2 diabetes, hypertension, or joint problems, the savings in future healthcare costs and the improvements in quality of life can be considerable. However, the financial reality must be sustainable for you; starting and then abruptly stopping treatment due to cost is a common scenario that often leads to weight regain and frustration.
It's also worth being aware of the ongoing supply issues that have affected some GLP-1 medications globally. Your GP can advise you on current availability and help you plan for any potential disruptions to your treatment.
GLP-1 drugs are powerful tools, but they deliver their best results when used as part of a comprehensive lifestyle approach. Think of the medication as creating a window of opportunity — a period during which your reduced appetite and cravings make it significantly easier to adopt and embed healthier habits that will serve you well regardless of whether you continue the medication.
Because GLP-1 medications reduce appetite so effectively, there's a genuine risk of not eating enough or of making poor nutritional choices with the smaller amounts you do consume. Your GP or a registered dietitian can help you prioritise protein-rich foods to preserve muscle mass, ensure you're getting adequate vitamins and minerals, and develop a sustainable eating pattern rather than a restrictive diet that's impossible to maintain.
Regular physical activity is non-negotiable for optimising outcomes. Cardiovascular exercise supports heart health and calorie expenditure, while resistance training is particularly important for maintaining lean muscle mass during weight loss. Even moderate increases in daily movement — such as walking more, taking the stairs, or incorporating short activity breaks throughout the day — can make a meaningful difference.
Weight management is deeply intertwined with psychological wellbeing. Many patients benefit from exploring their relationship with food, addressing emotional eating patterns, and building healthier coping mechanisms for stress. Your GP may recommend cognitive behavioural therapy (CBT) or other therapeutic approaches alongside medication to address these dimensions of your health.
Most patients begin to notice a reduction in appetite within the first week or two of starting treatment. Visible weight loss typically becomes apparent within the first month, though the rate varies between individuals. Clinical trials show average weight losses of 5–10% of body weight by three months and 15–20% by 12–15 months when combined with lifestyle changes. Your GP will track your progress at regular intervals and adjust your treatment plan accordingly.
GLP-1 medications can interact with certain other drugs. Because they slow gastric emptying, they can affect the absorption rate of oral medications, including some blood pressure tablets, oral contraceptives, and antibiotics. It's essential that your GP reviews your complete medication list before prescribing. In many cases, adjustments to timing or dosage can resolve potential interactions, but this assessment must be done by a qualified medical professional.
Current evidence supports the safety of GLP-1 medications for long-term use in appropriate patients under medical supervision. Some of these drugs have been used for over a decade in the management of type 2 diabetes, providing a relatively substantial body of safety data. However, as with any medication, long-term use requires ongoing monitoring through regular check-ups and blood tests to ensure no adverse effects are developing.
Ozempic and Wegovy both contain the active ingredient semaglutide, but Ozempic is licensed primarily for type 2 diabetes management (at lower doses), while Wegovy is specifically approved for weight management at a higher dose. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, and has shown slightly higher average weight loss in clinical trials. Your GP can explain which option is most appropriate for your individual circumstances.
Absolutely. Weight management is often connected to broader hormonal health. For women experiencing perimenopause or menopause, hormonal changes can significantly affect weight distribution and metabolism. Your GP may consider treatments such as hormone replacement therapy (HRT) alongside or instead of GLP-1 medications, depending on your specific clinical picture. A comprehensive assessment ensures all contributing factors are addressed.
GLP-1 weight loss drugs represent a genuine breakthrough in obesity medicine, offering meaningful results for people who have struggled with their weight despite sincere efforts with diet and exercise alone. But they are not magic injections, and they carry real considerations around side effects, cost, long-term commitment, and the necessity of lifestyle change.
The single most important thing you can do before starting treatment is have an open, thorough conversation with a qualified GP who can assess your individual health, explain the risks and benefits in the context of your specific situation, and provide the ongoing support you'll need to get the most from your treatment. That's the kind of personalised, evidence-based care that makes the difference between a short-term experiment and a lasting transformation.
The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Our medical centre is at 36 Spital Square, E1 6DY, City of London.
